Compare SDGR & GDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SDGR | GDRX |
|---|---|---|
| Founded | 1990 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 2020 | 2020 |
| Metric | SDGR | GDRX |
|---|---|---|
| Price | $18.16 | $3.68 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 9 |
| Target Price | ★ $21.00 | $3.66 |
| AVG Volume (30 Days) | 974.4K | ★ 1.2M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 45.14 | ★ 125.00 |
| EPS | N/A | ★ 0.03 |
| Revenue | $255,869,000.00 | ★ $796,853,000.00 |
| Revenue This Year | $0.76 | N/A |
| Revenue Next Year | $4.60 | $5.38 |
| P/E Ratio | ★ N/A | $124.00 |
| Revenue Growth | ★ 23.29 | 0.57 |
| 52 Week Low | $10.95 | $1.77 |
| 52 Week High | $23.02 | $5.61 |
| Indicator | SDGR | GDRX |
|---|---|---|
| Relative Strength Index (RSI) | 71.63 | 73.11 |
| Support Level | $17.26 | $2.54 |
| Resistance Level | $18.12 | N/A |
| Average True Range (ATR) | 0.65 | 0.18 |
| MACD | 0.17 | 0.04 |
| Stochastic Oscillator | 84.88 | 89.90 |
Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.